[1] Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, et al. Glioma. Nature reviews Disease primers 2015;1:15017.
[2] Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016;66:115-32.
[3] Ostrom QT, Gittleman H, Stetson L, Virk S, Barnholtz-Sloan JS. Epidemiology of Intracranial Gliomas. Progress in neurological surgery 2018;30:1-11.
[4] Chen H, Chen Y, Zhao Y, Fan W, Zhou K, Liu Y, et al. Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. American journal of epidemiology 2011;173:915-22.
[5] Wang D, Hu E, Wu P, Yuan W, Xu S, Sun Z, et al. Genetic variant near TERC influencing the risk of gliomas with older age at diagnosis in a Chinese population. Journal of neuro-oncology 2015;124:57-64.
[6] Kinnersley B, Houlston RS, Bondy ML. Genome-Wide Association Studies in Glioma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2018;27:418-28.
[7] Chen Y, Wu Y, Huang X, Qu P, Li G, Jin T, et al. Leukocyte telomere length: a novel biomarker to predict the prognosis of glioma patients. J Cancer Res Clin Oncol 2015;141:1739-47.
[8] Li S, Jin T, Zhang J, Lou H, Yang B, Li Y, et al. Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma. Cancer epidemiology 2012;36:283-7.
[9] Li G, Jin T, Liang H, Zhang Z, He S, Tu Y, et al. RTEL1 tagging SNPs and haplotypes were associated with glioma development. Diagn Pathol 2013;8:83.
[10] Olive V, Jiang I, He L. mir-17-92, a cluster of miRNAs in the midst of the cancer network. The international journal of biochemistry & cell biology 2010;42:1348-54.
[11] Molinari C, Salvi S, Foca F, Teodorani N, Saragoni L, Puccetti M, et al. miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer. OncoTargets and therapy 2016;9:2735-42.
[12] Yuan J, Tan L, Yin Z, Zhu W, Tao K, Wang G, et al. MIR17HG-miR-18a/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt/beta-catenin signalling. Cell death & disease 2019;10:454.
[13] Mao JT, Xue B, Smoake J, Lu QY, Park H, Henning SM, et al. MicroRNA-19a/b mediates grape seed procyanidin extract-induced anti-neoplastic effects against lung cancer. The Journal of nutritional biochemistry 2016;34:118-25.
[14] Cao S, Zheng J, Liu X, Liu Y, Ruan X, Ma J, et al. FXR1 promotes the malignant biological behavior of glioma cells via stabilizing MIR17HG. Journal of experimental & clinical cancer research : CR 2019;38:37.
[15] Chen P, Bai Y, Li Y, Yuan Y, Cheng Y, Pang J, et al. Association between polymorphisms of MIR17HG and risk of colorectal cancer in the Chinese Han population. 2019;7:e667.
[16] Chacon-Cortes D, Smith RA, Lea RA, Youl PH, Griffiths LR. Association of microRNA 17-92 cluster host gene (MIR17HG) polymorphisms with breast cancer. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2015;36:5369-76.
[17] Dobashi A, Tsuyama N, Asaka R, Togashi Y, Ueda K, Sakata S, et al. Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type. Genes, chromosomes & cancer 2016;55:460-71.
[18] Ellis JA, Ong B. The MassARRAY((R)) System for Targeted SNP Genotyping. Methods in molecular biology (Clifton, NJ) 2017;1492:77-94.
[19] Sun G, SiMa G, Wu C, Fan Y, Tan Y, Wang Z. Decreased MiR-17 in glioma cells increased cell viability and migration by increasing the expression of Cyclin D1, p-Akt and Akt. 2018;13:e0190515.
[20] Wang W, Zhang A, Hao Y, Wang G, Jia Z. The emerging role of miR-19 in glioma. 2018;22:4611-6.
[21] Schulte JH, Marschall T, Martin M, Rosenstiel P, Mestdagh P, Schlierf S, et al. Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma. Nucleic acids research 2010;38:5919-28.
[22] Cao Y, Wang P, Ning S, Xiao W, Xiao B, Li X. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network. Oncotarget 2016;7:41737-47.
[23] Leng X, Ma J, Liu Y, Shen S, Yu H, Zheng J, et al. Mechanism of piR-DQ590027/MIR17HG regulating the permeability of glioma conditioned normal BBB. Journal of experimental & clinical cancer research : CR 2018;37:246.
[24] Wu H, Huang T, Ye Z, Fu X, Hu K, Yang X. Correlation of MicroRNA 17-92 Cluster Host Gene (MIR17HG) Polymorphisms With Susceptibility and Prognosis for Multiple Myeloma. Clinical lymphoma, myeloma & leukemia 2019;19:e359-e66.
[25] Walther C, Mayrhofer M, Nilsson J, Hofvander J, Jonson T, Mandahl N, et al. Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis. Genes, chromosomes & cancer 2016;55:3-15.
[26] Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, et al. The epidemiology of glioma in adults: a "state of the science" review. Neuro-oncology 2014;16:896-913.